ChitogenX Company Description

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada.

It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair.

The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022.

ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.

ChitogenX Inc.

Country	Canada
Founded	2015
Industry	Biotechnology
Sector	Healthcare
CEO	Pierre Laurin

Contact Details

Address: 16667 Hymus Boulevard Kirkland, H9H 4R9 Canada
Phone	514 261 4735
Website	chitogenx.com

Stock Details

Ticker Symbol	CHGX
Exchange	Canadian Securities Exchange
Fiscal Year	February - January
Reporting Currency	CAD
ISIN Number	CA1699161032
SIC Code	2836

Key Executives

Name	Position
Pierre Laurin B.Sc.Pharm., M.Sc.	Interim Chief Executive Officer and Chairman
Luc Mainville M.B.A, M.B.A.	Senior Vice President and Chief Financial Officer
Guy-Paul Allard	Vice President of Legal Affairs and Corporate Secretary
Dr. Jonathan Sackier	Senior Vice President of Medical Affairs
Frédéric Dumais	Director of Communications and Investor Relations
Benedek Simo	Controller